Atlas Trials

HIV Antibodies

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HIV Antibodies

RecordFirmDate
Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) (NCT03538626)National Institute of Allergy and Infectious Diseases (NIAID)2018-06-21
Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults (NCT02599896)National Institute of Allergy and Infectious Diseases (NIAID)2015-11-16
Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults (NCT01993706)National Institute of Allergy and Infectious Diseases (NIAID)2013-11-19
VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected... (NCT01950325)National Institute of Allergy and Infectious Diseases (NIAID)2013-08-22

Track HIV Antibodies automatically

Every clearance here is in the API, with alerts when new ones post.